18 results
8-K
EX-3.1
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Unicycive Announces $50 Million Private Placement
4:28pm
8-K
EX-3.6
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.2
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.1
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.3
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.4
iu2 7xvspdd1
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.5
vhuucpzobcs
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.1
hf9u teyuiz11wj45p5
6 Mar 23
Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug Renazorb
5:02pm
S-1/A
EX-3.2
82ei7sb0sqnlbf t7jf
7 Jun 21
IPO registration (amended)
7:01am
S-1/A
EX-3.3
qioi 9pmqq
7 Jun 21
IPO registration (amended)
7:01am
S-1/A
EX-3.1
3vcgmnqj x9e
7 Jun 21
IPO registration (amended)
7:01am
S-1
EX-3.4
qw7 2zcovt2iq0yk3x
21 May 21
IPO registration
4:07pm
S-1
EX-3.5
c51yplmtogasu7rirnvc
21 May 21
IPO registration
4:07pm
DRS/A
EX-3.2
4e2oq3 9mm
29 Apr 21
Draft registration statement (amended)
12:00am
DRS/A
EX-3.1
2aj1ks64 205oo2
29 Apr 21
Draft registration statement (amended)
12:00am
DRS/A
EX-3.3
zw56k6r h8ydeveg7rtu
29 Apr 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next